Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer

Fig. 1

ICC and Western blotting of MPC1 and MPC2 expression in prostate cancer cell lines. a: Strong MPC1 (a) and MPC2 (b) immunoreactivities in the LNCaP cell line; Weak MPC1 (c) and MPC2 (d) protein expression in the DU145 cell line. All the photos were taken at 400X. b: Similar levels of MPC1 and MPC2 proteins revealed by Western blotting in these cell lines are shown as revealed with ICC shown in A, i.e.: low expression of both MPC1 and MPC2 in DU145 cell line, compared to the protein expression in LNCaP cell line. α–tubulin was used as loading control. Right penal shows quantified denstitometry of the Western blottings. Data are presented as mean ± SEM (n = 3 separate test). Statistical significance: ***P < 0.001

Back to article page